EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Navigating the AI Transformation in Healthcare

    Real Chemistrys expansion into Zurich is part of our broader objective to help clients by scaling internationally while maintaining a local mindset We are bringing our connected capabilities to one of Europes most influential hotspots sitting at the intersection of science innovation and investment This convergence is ideal for collaboration

KNOWLEDGE BANK

TOP ARTICLES

press releases Read more...

Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations

Amneal Pharmaceuticals Inc today announced that it has received US Food and Drug Administration FDA approval for additional strengths and vial presentations of iohexol injection mg iodinemL in mL mL

Aqemia and Sanofi Expand Their Research Collaboration

Aqemia the drug invention company combining generative AI and quantuminspired physics to invent small molecule drugs today announced the expansion of its multiyear research collaboration with the global pharmaceutical company

AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma

Forecasting insights and analytics is a strategic decisionmaking function within global product strategy and commercial departments in pharmaceutical companies Unlike operational or salesfocused functions

Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals

Angelini Pharma SpA Angelini Pharma international pharmaceutical company and part of Angelini Industries announces today the completion of its acquisition of Catalyst Pharmaceuticals Inc

16 - 19

Jul 2026

Bio Asia Taiwan 2026

Taipei Nangang Exhibition Cent...

20 - 22

Jul 2026

6th mRNA-Based Therapeutics Summit

The Westin Boston Seaport Dist...

20 - 22

Jul 2026

24 - 25

Jul 2026

26 - 30

Jul 2026

ADLM 2026

Anaheim, CA USA

27 - 28

Jul 2026

27 - 28

Jul 2026

27 - 28

Jul 2026

LATEST NEWS Read more...

European Commission approves JASCAYD® for IPF and PPF treatment in the EU

The European Commission EC has granted marketing authorisation for JASCAYD nerandomilast for the treatment of adults with idiopathic pulmonary fibrosis IPF and progressive pulmonary fibrosis PPF Boehringer Ingelheim announced

ThalassaX Therapeutics doses first patient in U.S. Phase I trial of CS231295

ThalassaX Therapeutics United States Ltd has announced that the first patient has been dosed in its US Phase I clinical trial of CS a brainpenetrant Aurora B kinase selective inhibitor developed

Boehringer Ingelheim Advances Obesity Pipeline with Phase II Trial of Triple Receptor Agonist

Boehringer Ingelheim has started a Phase II clinical trial of BI an investigational triple GLPGIPNPY receptor agonist for the treatment of people with obesity and overweight

Umoja Biopharma Receives FDA Clearance to Begin Clinical Trial of UB-VV400 In Vivo CAR T Cell Therapy

Umoja Biopharma has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for UBVV a CDdirected in vivo CAR T cell therapy for adults

Sinopia Biosciences Publishes Preclinical Study Supporting SB-0110 for Parkinson's Disease

Sinopia Biosciences has published preclinical research in Science Translational Medicine highlighting a new approach to treating Parkinsons disease The study supports the development of SB

Kairos Pharma Reports Positive Interim Safety Results from Phase 1 Trial of ENV-105 in EGFR-Mutated Lung Cancer

Kairos Pharma has reported positive interim safety results from its ongoing Phase clinical trial of ENV carotuximab in combination with osimertinib Tagrisso for patients with advanced EGFRmutated nonsmall cell lung cancer NSCLC